Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

about

Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

Item

http://www.wikidata.org/entity/Q39393770

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

@en

Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

@nl

type

Item

label

Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

@en

Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

@nl

prefLabel

Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

@en

Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

@nl

P1476

Performance of the XLIMUS Sirolimus-Eluting Coronary Stent in Very Complex Lesions.

@en

P2093

Amelia Focaccio

http://www.w3.org/2001/XMLSchema#string

Carlo Briguori

http://www.w3.org/2001/XMLSchema#string

Francesca De Micco

http://www.w3.org/2001/XMLSchema#string

Gabriella Visconti

http://www.w3.org/2001/XMLSchema#string

Giuseppe Signoriello

http://www.w3.org/2001/XMLSchema#string

Michael Donahue

http://www.w3.org/2001/XMLSchema#string

Vito Di Palma

http://www.w3.org/2001/XMLSchema#string

P2860

Stent thrombosis in randomized clinical trials of drug-eluting stents

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Clinical end points in coronary stent trials: a case for standardized definitions.

Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial.

Longitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience database.

Stent longitudinal integrity bench insights into a clinical problem.

Tools & Techniques: stent delivery in distal lesions.

Tornus catheter and rotational atherectomy in resistant chronic total occlusions.

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.

P304

559-568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOIC.12340

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27625144

http://www.w3.org/2001/XMLSchema#string